Veterinary Medicines

Amoksiklav 62,5 % ūdenī šķīstošs pulveris cūkām

Not authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate
Download as PDF

Product identification

Medicine name:
Amoksiklav 62,5 % ūdenī šķīstošs pulveris cūkām
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Pig
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    500.00
    milligram(s)
    /
    1.00
    gram(s)
  • Potassium clavulanate
    125.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Pig
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lek Pharmaceuticals d.d.
  • Sandoz S.R.L.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/00/1119
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 7/06/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 7/06/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 7/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."